Novel barbituric acid based leucocyte transmigration inhibitors as drug candidates for treating inflammatory diseases, autoimmune diseases and cancer

A. Gruzman (Inventor)

Research output: Patent

Original languageAmerican English
StatePublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Cite this